Will a new pill formula absorb the same? a trial puts it to the test
NCT ID NCT07756996
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This trial checks whether a new strength of ammoxetine hydrochloride enteric-coated tablets works the same as the original version in healthy adults. It also looks at how a high-fat meal affects the drug's absorption. Participants take single doses of both formulations, and researchers measure drug levels in the blood to compare them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ammoxetine hydrochloride enteric-coated tablets (new formulation)
- What this could lead to
- If the new tablet is shown to be equivalent, it could become a more convenient or cost-effective version of the medication.
- What could go wrong
- This is an early-stage trial in healthy volunteers, so results may not predict effects in patients. The new formulation might not match the original, and food could change absorption unexpectedly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suzhou Municipal Hospital
RECRUITINGSuzhou, Jiangsu, 215000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates
- Tracking a new Drug's journey through the body